Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T67310
(Former ID: TTDI01582)
|
|||||
Target Name |
Glutamate receptor ionotropic (GRI)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | General pain disorder [ICD-11: 8E43] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | LY-545694 | Drug Info | Phase 2 | Neuropathic pain | [2] | |
Discontinued Drug(s) | [+] 1 Discontinued Drugs | + | ||||
1 | NPS-846 | Drug Info | Terminated | Cerebrovascular ischaemia | [3] | |
Mode of Action | [+] 2 Modes of Action | + | ||||
Antagonist | [+] 1 Antagonist drugs | + | ||||
1 | LY-545694 | Drug Info | [1] | |||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | NPS-846 | Drug Info | [4] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019739) | |||||
REF 2 | ClinicalTrials.gov (NCT00785577) A Study for Treatment of Pain in Patients With Diabetic Neuropathy.. U.S. National Institutes of Health. | |||||
REF 3 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007143) | |||||
REF 4 | Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats. J Neurosurg. 1998 Jun;88(6):1066-74. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.